Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
Authors
Keywords
Cardiovascular risk, Probiotic, Nutraceutical, Hypercholesterolemia, LDL-cholesterol, Non-HDL cholesterol, Monacolin K
Journal
Nutrition Journal
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-22
DOI
10.1186/s12937-019-0438-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials
- (2019) Federica Fogacci et al. PHYTOTHERAPY RESEARCH
- Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents
- (2019) C Macchi et al. European Journal of Preventive Cardiology
- Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience
- (2018) Natalie C. Ward et al. CLINICAL CARDIOLOGY
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
- (2018) François Mach et al. EUROPEAN HEART JOURNAL
- Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper
- (2018) Andrea Poli et al. PHARMACOLOGICAL RESEARCH
- Prevention of cardiovascular disease: Much more is needed
- (2018) Guy G De Backer European Journal of Preventive Cardiology
- Impact of the gut microbiome in cardiovascular and autoimmune diseases
- (2018) Michael Weis CLINICAL SCIENCE
- Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes
- (2017) Jun He et al. MEDICINE
- FGF1 — a new weapon to control type 2 diabetes mellitus
- (2017) Emanuel Gasser et al. Nature Reviews Endocrinology
- Joint position statement on “Nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA)
- (2017) M. Pirro et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Regulation of PCSK9 by nutraceuticals
- (2017) Amir Abbas Momtazi et al. PHARMACOLOGICAL RESEARCH
- Genetic Architecture of Familial Hypercholesterolaemia
- (2017) Mahtab Sharifi et al. Current Cardiology Reports
- Liver fat accumulation is associated with circulating PCSK9
- (2016) Massimiliano Ruscica et al. ANNALS OF MEDICINE
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. ATHEROSCLEROSIS
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- The use of probiotic L. fermentum ME-3 containing Reg’Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study
- (2016) Tiiu Kullisaar et al. Nutrition Journal
- Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial
- (2015) Veronique Verhoeven et al. BMC Complementary and Alternative Medicine
- Risk identification and possible countermeasures for muscle adverse effects during statin therapy
- (2015) Paolo Magni et al. European Journal of Internal Medicine
- Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals
- (2015) Mikiko Shimizu et al. PLoS One
- Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients
- (2013) David J. Becker ANNALS OF INTERNAL MEDICINE
- Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus
- (2013) Massimiliano Ruscica et al. Journal of Clinical Lipidology
- Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
- (2012) S.H. Kasmas et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol
- (2009) Sara Andrade et al. JOURNAL OF DAIRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation